Roche has provided an update to the community announcing that they have restarted recruitment of RG6206, an investigational anti-myostatin adnectin, in ambulatory boys with Duchenne. PPMD will be hosting a webinar with Roche in the coming weeks and we look forward to learning more.
Read the update from Roche:
11 April 2018
Dear Duchenne community members,
We are happy to let you know that r…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this